Resonate Blends Inc KOAN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if KOAN is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.04
- Day Range
- $0.04–0.04
- 52-Week Range
- $0.01–0.10
- Bid/Ask
- $0.02 / $0.05
- Market Cap
- $3.38 Mil
- Volume/Avg
- 532 / 139,091
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 170.44
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Resonate Blends Inc engages in the discovery, development and marketing of products designed to better mankind. The company believes It is positioning its company as a leader in the field of Regenerative Medicine defined by the National Institute of Health using nutritionally designed products. Intended products are to be marketed under third-party label exemptions. It is focusing its current efforts on marketing licensed patent-pending natural stem cell mobilizing agents capable of enhancing each individual’s ability to mobilize their adult stem cells from their bone marrow.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.resonateblends.com
Valuation
|
Metric
|
KOAN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 170.44 |
Price/Cash Flow | — |
Price/Earnings
KOAN
Financial Strength
|
Metric
|
KOAN
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.31 |
Interest Coverage | −1.22 |
Quick Ratio
KOAN
Profitability
|
Metric
|
KOAN
|
|---|---|
Return on Assets (Normalized) | −182.10% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −105,971.99% |
Return on Assets
KOAN
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Xdbqtpdqcp | Slyf | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Ftvypqfgd | Sywtqh | $70.8 Bil | |
HLN
| Haleon PLC ADR | Qdcrfywb | Nmqjy | $37.7 Bil | |
VTRS
| Viatris Inc | Fzpxwmtt | Wcfbt | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Lfqybrjq | Sgdzr | $12.5 Bil | |
CTLT
| Catalent Inc | Cndxcmfz | Vbqmx | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Hhfymmmt | Zjxj | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Lnltxgyt | Tzbn | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Nddtjfxjv | Mhttqz | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Wzjfcswdn | Gyj | $2.9 Bil |